User profiles for H. J. Larson

Heidi J Larson

Professor, London School of Hygiene & Tropical Medicine
Verified email at lshtm.ac.uk
Cited by 87437

[HTML][HTML] A global survey of potential acceptance of a COVID-19 vaccine

…, SC Ratzan, A Palayew, LO Gostin, HJ Larson… - Nature medicine, 2021 - nature.com
Several coronavirus disease 2019 (COVID-19) vaccines are currently in human trials. In June
2020, we surveyed 13,426 people in 19 countries to determine potential acceptance rates …

Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to …

…, GA Kumar, M Kutz, Q Lan, HJ Larson… - JAMA …, 2017 - jamanetwork.com
Importance Cancer is the second leading cause of death worldwide. Current estimates on
the burden of cancer are needed for cancer control planning. Objective To estimate mortality, …

[HTML][HTML] Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990 …

…, M Griswold, SI Hay, Y Kinfu, HH Kyu, HJ Larson… - The lancet, 2016 - thelancet.com
Background The Global Burden of Diseases, Injuries, and Risk Factors Study 2015 provides
an up-to-date synthesis of the evidence for risk factor exposure and the attributable burden …

[HTML][HTML] Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for …

…, Y Kinfu, XR Kulikoff, M Kutz, HH Kyu, HJ Larson… - The lancet, 2016 - thelancet.com
Background Improving survival and extending the longevity of life for all populations requires
timely, robust evidence on local mortality levels and trends. The Global Burden of Disease …

[HTML][HTML] Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA

…, SJ Piatek, K De Graaf, HJ Larson - Nature human …, 2021 - nature.com
Widespread acceptance of a vaccine for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
will be the next major step in fighting the coronavirus disease 2019 (COVID-19…

Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

…, M Salcher-Konrad, AJ Pollard, HJ Larson… - The Lancet, 2021 - thelancet.com
The COVID-19 pandemic is unlikely to end until there is global roll-out of vaccines that
protect against severe disease and preferably drive herd immunity. Regulators in numerous …

Understanding vaccine hesitancy around vaccines and vaccination from a global perspective: a systematic review of published literature, 2007–2012

HJ Larson, C Jarrett, E Eckersberger, DMD Smith… - Vaccine, 2014 - Elsevier
Vaccine “hesitancy” is an emerging term in the literature and discourse on vaccine decision-making
and determinants of vaccine acceptance. It recognizes a continuum between the …

[HTML][HTML] Mapping global trends in vaccine confidence and investigating barriers to vaccine uptake: a large-scale retrospective temporal modelling study

…, C Simas, E Karafillakis, P Paterson, HJ Larson - The Lancet, 2020 - thelancet.com
Background There is growing evidence of vaccine delays or refusals due to a lack of trust in
the importance, safety, or effectiveness of vaccines, alongside persisting access issues. …

[HTML][HTML] The state of vaccine confidence 2016: global insights through a 67-country survey

HJ Larson, A De Figueiredo, Z Xiahong, WS Schulz… - …, 2016 - thelancet.com
Background Public trust in immunization is an increasingly important global health issue.
Losses in confidence in vaccines and immunization programmes can lead to vaccine …

[HTML][HTML] Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

…, L Dandona, PW Gething, SI Hay, Y Kinfu, HJ Larson… - The lancet, 2016 - thelancet.com
Background In transitioning from the Millennium Development Goal to the Sustainable
Development Goal era, it is imperative to comprehensively assess progress toward reducing …